Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 27 Jul 2026 for Quest Diagnostics INC, €13k.
Filing timeline
BuySaleVicky B. Gregg
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Vicky B. Gregg: trading record in brief
Vicky B. Gregg sits as Director at three US companies: Quest Diagnostics Inc (33 filings), Acadia Healthcare Company, Inc. (11) and Team Health Holdings Inc. (3). The record has 47 filings since January 5, 2016 and very few market trades: 4 sales worth EUR 896,114 in total, with a median of EUR 203,194, and no purchase. The three highest are EUR 292,450 on February 23, 2024, EUR 208,072 on November 25, 2025 and EUR 198,317 on February 5, 2025, all at Quest Diagnostics Inc.
The rest is 30 grants, 2 option exercises and 11 other lines.
Yearly volume stayed low for the first half of the period, from 2 to 5 filings a year, before doubling: 6 in 2023, then 8 in 2024 and 8 in 2025. Six filings fall in the last twelve months, one of them a sale. Filings are published a median of 2 days after the trade. 2, 2 and 2 trades by Gregg fall within 30 days of colleagues at Quest Diagnostics Inc, in that order. All on the same side. Colleagues in order: Catherine T. Doherty, Mark E. Delaney and Michael E. Prevoznik.
Companies and markets linked to Vicky B. Gregg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
72 shares@ US$206.8080.0001% mcap1.5% of flowCommon StockSEC:0001022079-26-000084:0
1,142 shares0Common StockSEC:0001510304-26-000005:0
68 shares@ US$194.6980.0001% mcap1.3% of flowCommon StockSEC:0001022079-26-000048:0
67 shares@ US$183.5130.0001% mcap1.2% of flowCommon StockSEC:0001510304-26-000002:0
1,250 shares@ US$191.7623.6% of flowCommon StockSEC:0001022079-25-000232:0
70 shares@ US$189.0820.0001% mcap1.3% of flowCommon StockSEC:0001022079-25-000226:0
79 shares@ US$167.4951.3% of flowCommon StockSEC:0001022079-25-000185:0
7,032 shares0Common StockSEC:0000950170-25-079850:0
1,203 shares0Common StockSEC:0001022079-25-000148:0
68 shares@ US$164.4221.1% of flowCommon StockSEC:0001022079-25-000127:0
1,250 shares@ US$164.56822.5% of flowCommon StockSEC:0001022079-25-000022:0
72 shares@ US$158.0371.2% of flowCommon StockSEC:0001022079-25-000018:0
76 shares@ US$149.3711.2% of flowCommon StockSEC:0001022079-24-000200:0
77 shares@ US$146.9731.2% of flowCommon StockSEC:0001022079-24-000164:0
2,414 shares0Common StockSEC:0000950170-24-065503:0
1,482 shares0Common StockSEC:0001022079-24-000121:0
81 shares@ US$126.2441.1% of flowCommon StockSEC:0001022079-24-000107:0
2,500 shares@ US$85.56100.0% of flowCommon StockSEC:0000950170-24-027348:0
2,500 shares@ US$126.638633.1% of flowCommon StockSEC:0001022079-24-000052:0
88 shares@ US$129.3271.2% of flowCommon StockSEC:0001022079-24-000017:0
92 shares@ US$122.8631.2% of flowCommon StockSEC:0001022079-23-000165:0
78 shares@ US$144.5911.2% of flowCommon StockSEC:0001022079-23-000138:0
2,229 shares0Common StockSEC:0000899243-23-013386:0
1,369 shares0Common StockSEC:0001022079-23-000117:0
72 shares@ US$143.0811.1% of flowCommon StockSEC:0001022079-23-000083:0
25 of 47 declarations
